Abstract:Abstract Introduction Prior studies have examined the association between insomnia with short sleep duration (ISSD) with hypertension in middle-aged adults. However, no study to date has examined its association with elevated blood pressure (eBP) and flow-mediated dilation (FMD) in young adults. Methods We studied 270 young adults (median 25y, 53% female, 24% racial/ethnic minority) from the Penn State Child Cohort who underwent a 9-hour polysomnography (PSG) recording and Doppler ultrasound to asses FMD. The average of three consecutive BP readings was used to calculate resting mean arterial pressure (MAP) in the evening and morning. eBP was defined as systolic BP ≥120 mmHg, diastolic BP ≥80 mmHg, hypertension diagnosis, and/or antihypertensive medication use. Insomnia symptoms were defined as difficulties initiating or maintaining sleep, insomnia diagnosis or complaint, and/or sleep medication use. PSG-measured short sleep duration was defined by the median of the sample (i.e., < 7-h), identifying normal sleep duration (NSD), short sleep duration (SSD), insomnia with normal sleep duration (INSD) and ISSD. Multivariate general linear models tested mean differences in MAP and FMD across the four groups adjusting for sex, race/ethnicity, age, waist circumference, sleep apnea, cardiometabolic disorders, substance and medication use. A logistic regression model examined the association of the four groups with the presence of eBP, while accounting for the same covariables. Results Compared to NSD (84.6±1.2) or INSD (85.7±0.8), ISSD showed significantly higher evening MAP levels (88.0±0.8; p=0.022 and p=0.044, respectively), a finding replicated by morning MAP levels. Neither INSD (p=0.466) nor SSD (86.9±1.3; p=0.190) showed significantly elevated MAP levels compared to NSD. Similarly, ISSD (9.4±0.5; p=0.012), but not INSD (10.3±0.5; p=0.170) or SSD (10.3±0.7; p=0.257), showed significantly lower FMD levels compared to NSD (11.4±0.6). The odds of eBP were significantly increased in ISSD (OR=2.5, 95%CI=1.0-6.2; p=0.044), but not in INSD (OR=1.7, 95%CI=0.7-4.3; p=0.244) or SSD (OR=1.4, 95%CI=0.5-4.1; p=0.580), compared to NSD. Conclusion ISSD, but not INSD, is associated with hypertension and endothelial dysfunction in young adults. Clinical trials should examine whether improving insomnia symptoms and lengthening objective sleep duration in this phenotype may lead to favorable cardiovascular outcomes. Support (if any) NIH (R01HL136587, R01MH118308, UL1TR00127)

0392 Insomnia with Short Sleep Duration Is Associated with Heart Disease and Stroke: Evidence from the UK Biobank Cohort

0333 INSOMNIA WITH OBJECTIVE SHORT SLEEP DURATION IS ASSOCIATED WITH INCIDENT CARDIOVASCULAR AND/OR CEREBROVASCULAR DISEASE

Insomnia with objective but not subjective short sleep duration is associated with incident cardiovascular and/or cerebrovascular disease

0852 Insomnia with Objective, but Not Subjective, Short Sleep Duration is Associated with Increased Risk of Incident Hypertension

Insomnia with objective short sleep duration and risk of incident cardiovascular disease and all-cause mortality: Sleep Heart Health Study

0334 INSOMNIA WITH OBJECTIVE SHORT SLEEP DURATION IS ASSOCIATED WITH METABOLIC SYNDROME

Abstract 10978: Sleep Duration and Risks of Cardiovascular Disease Onset and Mortality among Patients with Type 2 Diabetes

0393 Insomnia with Short Sleep Duration Is Associated with Hypertension and Endothelial Dysfunction in Young Adults

A meta-analysis of the association between insomnia with objective short sleep duration and risk of hypertension

Insomnia with objective short sleep duration is associated with hypertension

Obstructive sleep apnea comorbid with insomnia symptoms and objective short sleep duration is associated with clinical and preclinical cardiometabolic risk factors: Clinical implications

Associations of sleep phenotypes with severe intentional self-harm: a prospective analysis of the UK Biobank cohort

Insomnia with objective, but not subjective, short sleep duration is associated with increased risk of incident hypertension: the Sleep Heart Health Study.

Sleep duration irregularity and risk for incident cardiovascular disease in the UK Biobank

0367 The Independent and Interactive Effects of Insomnia Symptoms and Short Sleep on Sleep Physiology

Associations of Accelerometer-measured Sleep Duration with Incident Cardiovascular Disease and Cardiovascular Mortality

The association of insomnia disorder characterised by objective short sleep duration with hypertension, diabetes and body mass index: A systematic review and meta-analysis

Association Between Accelerometer-Measured Irregular Sleep Duration and Type 2 Diabetes Risk: A Prospective Cohort Study in the UK Biobank

Habitual sleep duration and insomnia and the risk of cardiovascular events and all-cause death: report from a community-based cohort

0106 Cognitive-Emotional Features of Insomnia Phenotypes Based on Objective Sleep Duration in Young Adults

Accelerometer-derived sleep onset timing and cardiovascular disease incidence: a UK Biobank cohort study